SCHEMBL10303179

SCHEMBL10303179

CCCC(O)c1ccc(OCc2ccc(-c3ccc(OCC)c(F)c3F)cc2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 4/20 0.40
▸ FAAH O00519 1/20 0.39
▸ PTGS2 P35354 3/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ S1PR5 Q9H228 1/20 0.35
▸ PPARD Q03181 3/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ ERN1 O75460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13586388 0.94 FAAH (0.42) FFAR1FAAHS1PR5PPARDFFAR4
SCHEMBL12822822 0.92 KMT2A (0.37) FFAR1FAAHPTGS2PTGS1FFAR4
SCHEMBL12821312 0.92 KMT2A (0.37) FFAR1FAAHPTGS2PTGS1FFAR4
SCHEMBL10303195 0.91 FFAR1 (0.39) FFAR1FAAHMRGPRX4S1PR5FFAR4
SCHEMBL12823851 0.90 FFAR1 (0.43) FFAR1FAAHPPARD
SCHEMBL10303094 0.89 FFAR1 (0.35) FFAR1FAAHMRGPRX4S1PR5FFAR4
SCHEMBL10303187 0.89 FFAR1 (0.35) FFAR1FAAHMRGPRX4S1PR5FFAR4
SCHEMBL12823598 0.88 FFAR1 (0.36) FFAR1FAAHMRGPRX4S1PR5FFAR4
SCHEMBL10303133 0.88 FFAR1 (0.41) FFAR1FAAHPTGS2PTGS1MRGPRX4
SCHEMBL12719262 0.88 FFAR1 (0.43) FFAR1FAAHPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 — — US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 — — US disclosed
EP-2266941-A1 TRICYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE Chisso Corporation (JP) 2010-12-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 FFAR1 681/4885FAAH 1436/4885PTGS2 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback